Adrenoleukodystrophy other imaging findings: Difference between revisions

Jump to navigation Jump to search
 
(No difference)

Latest revision as of 19:22, 28 June 2020

Adrenoleukodystrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenoleukodystrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adrenoleukodystrophy other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenoleukodystrophy other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenoleukodystrophy other imaging findings

CDC on Adrenoleukodystrophy other imaging findings

Adrenoleukodystrophy other imaging findings in the news

Blogs on Adrenoleukodystrophy other imaging findings

Directions to Hospitals Treating Adrenoleukodystrophy

Risk calculators and risk factors for Adrenoleukodystrophy other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Proton Magnetic Resonance Spectroscopic (MRS) imaging and Diffusion Tensor Imaging (DTI) may be helpful in the diagnosis of adrenoleukodystrophy

Other Imaging Findings

Proton Magnetic Resonance Spectroscopic (MRS) imaging and Diffusion Tensor Imaging (DTI) may be helpful in the diagnosis of adrenoleukodystrophy.

  • These imaging techniques show changes in metabolic rates and water diffusion parameters. MRS imaging was able to demonstrate low NAA and high choline levels in white matter as a first indicator of metabolic dysfunction, prior to MRI changes in ALD. [1]
  • High directionality and structure of white matter, resulting from the directional morphology of myelinated axons, is quantified by a higher relative Fractional anisotropic (FA) with DTI.[2] A decreased FA can be seen in central cALD lesion areas.[1]

References

  1. 1.0 1.1 Pizzini F, Fatemi AS, Barker PB, Nagae-Poetscher LM, Horská A, Zimmerman AW; et al. (2003). "Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease". AJNR Am J Neuroradiol. 24 (8): 1683–9. PMID 13679292.
  2. Turk, Bela R.; Moser, Ann B.; Fatemi, Ali (2017). "Therapeutic strategies in adrenoleukodystrophy". Wiener Medizinische Wochenschrift. 167 (9–10): 219–226. doi:10.1007/s10354-016-0534-2. ISSN 0043-5341.

Template:WH Template:WS